Co-Authors
This is a "connection" page, showing publications co-authored by Saad Nseir and Lila Bouadma.
Connection Strength
0.252
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2099-2107.
Score: 0.050
-
Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU. Ann Intensive Care. 2018 Nov 03; 8(1):104.
Score: 0.050
-
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial. Trials. 2018 Mar 05; 19(1):157.
Score: 0.047
-
Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med. 2018 Feb; 37(1):83-98.
Score: 0.046